University Of North Carolina at Chapel Hill — Chapel Hill, North Carolina

University Of North Carolina at Chapel Hill is a clinical research site located in Chapel Hill, North Carolina, United States 27599.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

University Of North Carolina at Chapel Hill has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Hepatitis C, Cutaneous Squamous Cell Carcinoma, Advanced Cutaneous Squamous Cell Carcinoma.

Sponsors: XTL Biopharmaceuticals, Replimune Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University Of North Carolina at Chapel Hill?

University Of North Carolina at Chapel Hill has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University Of North Carolina at Chapel Hill conducted?

University Of North Carolina at Chapel Hill has 2 clinical trials on record, with 1 currently active. Their work covers Hepatitis C, Cutaneous Squamous Cell Carcinoma, Advanced Cutaneous Squamous Cell Carcinoma.

Is University Of North Carolina at Chapel Hill accredited by Crixeo Health?

University Of North Carolina at Chapel Hill has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University Of North Carolina at Chapel Hill?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.